title: Cytomegalovirus associated hemophagocytic lymphohistiocytosis in patients suffering from Crohn's disease treated by azathioprine: a series of four cases.
authors.forename: Yohan
authors.initials: Y
authors.lastname: N'Guyen
authors.forename: Sonia
authors.initials: S
authors.lastname: Baumard
authors.forename: Jean Hugues
authors.initials: JH
authors.lastname: Salmon
authors.forename: Louis
authors.initials: L
authors.lastname: Lemoine
authors.forename: Nicolas
authors.initials: N
authors.lastname: Lévêque
authors.forename: Amélie
authors.initials: A
authors.lastname: Servettaz
authors.forename: Roland
authors.initials: R
authors.lastname: Jaussaud
authors.forename: Christophe
authors.initials: C
authors.lastname: Strady
authors.forename: Laurent
authors.initials: L
authors.lastname: Andreoletti
mesh_terms: D000328:Adult; D001379:Azathioprine / Q000009:adverse effects*; D003093:Colitis, Ulcerative / Q000150:complications / Q000188:drug therapy*; D003424:Crohn Disease / Q000150:complications / Q000188:drug therapy*; D003587:Cytomegalovirus / Q000472:pathogenicity*; D003586:Cytomegalovirus Infections / Q000150:complications* / Q000821:virology; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D051359:Lymphohistiocytosis, Hemophagocytic / Q000139:chemically induced* / Q000821:virology*; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents; D001379:Azathioprine